Pharma & Speciality Chemicals

The pharmaceutical industry allows people to prolong their lives and cure, or mitigate, conditions which for previous generations would have had severe consequences. Speciality chemicals uses the high quality ingredients from Fine Chemical producers to create functionalised molecules with properties which consumers value.


Pharma & Speciality Chemicals
Industry Challenges

Generic drugs threaten the profitability of Pharma blockbusters which require years and millions of dollars to develop and commercialise. The technological growth in devices and personal data availability offers opportunities for patients and medical practitioners, but could threaten traditional treatment methods. Speciality Chemical producers have to obtain feedstocks which are in demand across different industries, and meet changing consumer needs. Agrochemicals aim to support the need for resilient and high yield crop production, while flavours and fragrances are sold into an increasingly diverse marketplace.

Pharma & Speciality Chemicals
Compact high-pressure platform for various screening experiments in the pharmaceutical industry

Our new high-pressure platform enables the broad screening of diverse experiments in pharmaceutical research in the shortest time and at high throughput. This is realized by the compact and modular design as well as the integration of 4 commercially available microtiter plates. The platform covers a wide range of pharmaceutical R&D from hydrogenation, carbonylation, screening of catalysts and solvents as well as slurry phase synthesis to high throughput experiments.

Download Flyer (PDF)

Case Studies

ILS has helped Pharma and Speciality Chemical companies accelerate research projects through advanced hardware.

Box Icon Syngenta


Syngenta wanted to increase the reaction throughput by, generate high quality data and avoid cross contamination between reactors. The reactor system ILS developed allowed them to quadruple their throughput with a unit which is straight forward to operate.

Box Icon Bayer


Bayer approached ILS to request a cost effective unit for hydrogenation studies. It needed to be able to operate around the clock and produce good quality data.

Box Icon DSM


DSM were interested in a parallel reactor system that was simple to use and could reach high temperatures. They needed to run research projects rapidly and wanted a collaborative company with good engineering abilities.


Discover how to save time when commissioning units

Hear ILS CEO Anton Nagy describe time-saving and practical tips in a series of short videos. You'll learn some of the methods which help ILS manage risk and avoid delays when they deliver highly sophisticated reactor systems.

Download Flyer
for high-pressure R&D-screening platform